ProfileGDS4132 / 227619_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 35% 48% 35% 37% 28% 45% 37% 32% 38% 35% 39% 37% 41% 40% 34% 36% 37% 34% 37% 40% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 10189.114735
GSM201543Muscle PCOS pioglitazone 121120.17548
GSM201544Muscle PCOS pioglitazone 16191.826935
GSM201545Muscle PCOS pioglitazone 201101.94637
GSM201829Muscle PCOS pioglitazone 23172.868828
GSM201830Muscle PCOS pioglitazon 251121.62245
GSM201831Muscle PCOS pioglitazone 27194.67737
GSM201832Muscle PCOS pioglitazone 3180.553832
GSM201833Muscle PCOS pioglitazone 4191.384538
GSM201834Muscle PCOS pioglitazone 8187.786535
GSM201835Muscle PCOS after pioglitazone 10287.504339
GSM201836Muscle PCOS after pioglitazone 12283.675737
GSM201837Muscle PCOS after pioglitazone 16290.767441
GSM201838Muscle PCOS after pioglitazone 20293.436840
GSM201839Muscle PCOS after pioglitazone 23277.699434
GSM201840Muscle PCOS after pioglitazone 25287.467536
GSM201841Muscle PCOS after pioglitazone 27280.670137
GSM201842Muscle PCOS after pioglitazone 3268.310634
GSM201843Muscle PCOS after pioglitazone 4292.561137
GSM201844Muscle PCOS after pioglitazone 8298.551240